glp-1 latest analogs, new trend in obesity treatment, become even more effective < Pharma < Article The Evolution of GLP-1: Personalized

PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome

OHare, T

BPC-157 does not have a single defined receptor rather, it modulates multiple convergent pathways: VEGF-VEGFR2-eNOS (angiogenesis and NO production), FAK-paxillin-actin (cytoskeletal remodelling and cell migration), NF-B suppression (anti-inflammatory), PI3K-Akt-Bcl-2 (anti-apoptotic), and EGR1-driven collagen/fibronectin gene transcription

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice

In the CAA, Glp1r + Chat + neurons were dispersed rostro-caudally between the T1 and L2 segments that contain both SPNs and cholinergic interneurons 36